Renee Lentini - 30 Jun 2023 Form 4 Insider Report for ImmunoGen, Inc.

Role
V.P.-FIN., PRIN. ACCTG. OFF.
Signature
/s/ Renee Lentini
Issuer symbol
N/A
Transactions as of
30 Jun 2023
Net transactions value
+$12,940
Form type
4
Filing time
05 Jul 2023, 17:55:13 UTC
Previous filing
07 Feb 2023
Next filing
04 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $12,940 +3,195 +16% $4.05* 22,843 30 Jun 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from January 1, 2023 through June 30, 2023.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2023.